Ask Warren

Hanmi Science

008930 · KOSPI · ₩008930 · 한미사이언스

₩41,450▲ ₩50 (0.12%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +4.28%
Market cap
₩2.8T
Enterprise value
₩2.9T
P/E
18.8×
P/B
2.7×
Dividend yield
0.7%
ROE
14.2%
Net margin
10.7%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−35.0% from the high

₩25,600Today: ₩41,100 – ₩45,350₩63,800

Returns

  • 1W−4.9%
  • 1M−20.9%
  • 3M+23.5%
  • 6M+9.1%
  • YTD+14.3%
  • 1Y+4.3%
Volume today
269,714
0.9× the 20-day average
Traded today
₩11B
Listed shares
68,391,550
EPS (12 months)
₩2,207
Earnings yield 5.3%
SellBuy
AI research · Update noteHanmi Science: Reports of Share Seizure and Tender Offer Rule Controversy Involving Shin Dong-kookThe latest news raises questions about control of the company, but it is based on press reports and the data does not show how or whether they will be resolved.Read the full report →

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

39Quiet
  • BuzzQuietBuzz 39 of 100 (50 is a normal day for this stock).
  • SentimentNegativeNews: Sales grew, but quarterly operating profit fell sharply. Community: 0 bullish, 0 bearish posts this week.
  • MomentumWeak-20.4% over the last month; the price is below its 20-day average.
  • News impactHigh14 news items and filings in two weeks; 1 rated high impact, 5 medium.

Signals describe activity, not recommendations. Not financial advice.

Leveraged ETF flows

Estimated leveraged-ETF rebalance on Oct 28: buy ₩884M at the close (6.0% of 20-day average trading value)

Sep 29Last 20 trading days (% of average trading value)Oct 28

On its 26 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 3.4% of trading value and pointed the same way 9 of 26 times.

  • 2× KODEX Leverage ₩460M
  • -2× KODEX 200 Futures Inverse 2X ₩272M
  • -1× KODEX Inverse ₩51M
  • 2× TIGER 200IT Leverage ₩33M
  • 2× TIGER Leverage ₩19M

Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.

Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.

Estimate based on ETF size and daily moves; actual trades may differ.

ETFs holding this

All ETFs →

Held by 32 funds.

Estimated from the funds' index or underlying stock.

Futures and options

All stock futures →

Futures (2026-11): 41,150

Basis −0.72% · implied rate −17.7%

Open interest 21,753 contracts

Futures and options can lose more than you put in. Figures describe the market; they are not predictions or recommendations. Paper trading only.

Hanmi Science stock overview

Hanmi Science (한미사이언스, KRX: 008930) is listed on KOSPI, in the Holding companies sector. Hanmi Science is a business holding company that earns revenue from equity income of its subsidiaries, patent and trademark royalties, healthcare operations, and management of affiliates. Its shares closed at ₩41,450 on Oct 28, 2026, up 0.12% on the day, giving it a market value of ₩2.8T.

Key facts

Market cap
₩2.8T
Sector
Holding companies
Latest price change
+0.12%
As of
Oct 28, 2026
Main business
Hanmi Science is a business holding company that earns revenue from equity income of its subsidiaries, patent and trademark royalties, healthcare operations, and management of affiliates.

Quick answers about Hanmi Science

What does Hanmi Science do?
Hanmi Science is a business holding company that earns revenue from equity income of its subsidiaries, patent and trademark royalties, healthcare operations, and management of affiliates. Its segments include the holding business, a healthcare business covering medical devices, consumer health food and beauty products, and pharma-focused IT solutions, a pharmaceutical wholesale business operating the HMP Mall B2B e-commerce platform and a nationwide sales network serving pharmacies and hospitals, and other operations. The company operates in South Korea and is developing new growth drivers and new business investments.
What is the market cap of Hanmi Science?
The market capitalisation of Hanmi Science was ₩2.8T at the close on Oct 28, 2026.
Who are the largest shareholders of Hanmi Science?
According to the latest official filings, the largest reported holders are Song Young-sook (71.15%, as of Oct 16, 2026); Shin Dong-guk (28.15%, as of Aug 12, 2026); Killington (9.81%, as of Apr 16, 2025).
When is the next earnings report from Hanmi Science?
Korean companies rarely announce results dates in advance. Based on when Hanmi Science filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Hanmi Science?
Yes. The National Pension Service held 6.27% of Hanmi Science shares as of Dec 31, 2025.

Company profile

Hanmi Science is a business holding company that earns revenue from equity income of its subsidiaries, patent and trademark royalties, healthcare operations, and management of affiliates. Its segments include the holding business, a healthcare business covering medical devices, consumer health food and beauty products, and pharma-focused IT solutions, a pharmaceutical wholesale business operating the HMP Mall B2B e-commerce platform and a nationwide sales network serving pharmacies and hospitals, and other operations. The company operates in South Korea and is developing new growth drivers and new business investments.

Written by AI from the company's latest annual report.

Korean name
한미사이언스
Sector
Holding companies
Themes
Holding companiesPharmaceuticals
CEO
김재교
Founded
Jun 1973
Listed
Jun 1988
Listed shares
68,391,550
Fiscal year ends
Month 12
Website
www.hanmiscience.co.kr

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Hanmi Science / 한미사이언스 / 008930 / KRX:008930

Source: KRX statistical information